TrialHeadache2015

A randomized, double-blind, placebo-controlled study of breath powered nasal delivery of sumatriptan powder (AVP-825) in the treatment of acute migraine (The TARGET Study).

Roger K Cady et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.